Follow the people · Insider
Jack Kaye
Jack Kaye files insider transactions with the SEC as a director of uniQure (QURE). We hold 5 disclosed purchases and sales filed since 22 June 2007, 3 of them in the last 90 days.
- Files forQURE
- Disclosed buys and sells5 in all, 3 in the last 90 days
- Last disclosure2 July 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 January 2017 — 30 June 2026Director · uniQure (QURE)61 Form 4 lines · source: SEC Form 4
- Filed 25 June 2019 — 2 January 2026Director · Dyadic International (DYAI)30 Form 4 lines · source: SEC Form 4
- Filed 19 June 2007 — 17 June 2015Director · Keryx Biopharmaceuticals (KERX)29 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 4,107 shares of uniQureSEC Form 42 July 2026Ordinary Shares · traded 30 June 2026 · filed 2 July 2026
- ▼ sold on the open market 4,107 shares of uniQureSEC Form 42 July 2026Ordinary Shares · traded 30 June 2026 · filed 2 July 2026
- exercised options over 17,060 shares of uniQureSEC Form 42 July 2026Ordinary Shares · traded 30 June 2026 · filed 2 July 2026
- ▼ sold on the open market 17,060 shares of uniQureSEC Form 42 July 2026Ordinary Shares · traded 30 June 2026 · filed 2 July 2026
- exercised options over 4,107 shares of uniQure (a derivative holding)SEC Form 42 July 2026Stock Option (Right to Buy) · traded 30 June 2026 · filed 2 July 2026
- exercised options over 17,060 shares of uniQure (a derivative holding)SEC Form 42 July 2026Stock Option (Right to Buy) · traded 30 June 2026 · filed 2 July 2026
- exercised options over 5,295 shares of uniQureSEC Form 422 June 2026Ordinary Shares · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 5,295 shares of uniQureSEC Form 422 June 2026Ordinary Shares · traded 17 June 2026 · filed 22 June 2026
- exercised options over 5,295 shares of uniQure (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 17 June 2026 · filed 22 June 2026
- was granted 7,550 shares of uniQureSEC Form 412 June 2026Ordinary Shares · traded 10 June 2026 · filed 12 June 2026
- ▼ sold on the open market 1,993 shares of uniQureSEC Form 412 June 2026Ordinary Shares · traded 11 June 2026 · filed 12 June 2026
- was granted 13,980 shares of uniQure (a derivative holding)SEC Form 412 June 2026Stock Option (Right to Buy) · traded 10 June 2026 · filed 12 June 2026
- exercised options over 2,645 shares of uniQureSEC Form 45 June 2026Ordinary Shares · traded 3 June 2026 · filed 5 June 2026
- ▼ sold on the open market 2,645 shares of uniQureSEC Form 45 June 2026Ordinary Shares · traded 3 June 2026 · filed 5 June 2026
- exercised options over 2,645 shares of uniQure (a derivative holding)SEC Form 45 June 2026Stock Option (Right to Buy) · traded 3 June 2026 · filed 5 June 2026
- exercised options over 6,390 shares of uniQureSEC Form 412 January 2026Ordinary Shares · traded 9 January 2026 · filed 12 January 2026
- ▼ sold on the open market 6,390 shares of uniQureSEC Form 412 January 2026Ordinary Shares · traded 9 January 2026 · filed 12 January 2026
- exercised options over 6,390 shares of uniQure (a derivative holding)SEC Form 412 January 2026Stock Option (Right to Buy) · traded 9 January 2026 · filed 12 January 2026
- exercised options over 6,390 shares of uniQure (a derivative holding)SEC Form 412 January 2026Stock Option (Right to Buy) · traded 9 January 2026 · filed 12 January 2026
- exercised options over 6,390 shares of uniQureSEC Form 412 January 2026Ordinary Shares · traded 9 January 2026 · filed 12 January 2026
- ▼ sold on the open market 6,390 shares of uniQureSEC Form 412 January 2026Ordinary Shares · traded 9 January 2026 · filed 12 January 2026
- exercised options over 21,552 shares of Dyadic InternationalSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- exercised options over 21,552 shares of Dyadic International (a derivative holding)SEC Form 46 January 2026Restricted Stock Unit · traded 2 January 2026 · filed 6 January 2026
- was granted 67,500 shares of Dyadic International (a derivative holding)SEC Form 46 January 2026Stock Option · traded 2 January 2026 · filed 6 January 2026
- exercised options over 21,552 shares of Dyadic International (a derivative holding)SEC Form 46 January 2026Restricted Stock Unit · traded 2 January 2026 · filed 6 January 2026
- was granted 67,500 shares of Dyadic International (a derivative holding)SEC Form 46 January 2026Stock Option · traded 2 January 2026 · filed 6 January 2026
- was granted 39,894 shares of Dyadic International (a derivative holding)SEC Form 46 January 2026Restricted Stock Unit · traded 2 January 2026 · filed 6 January 2026
- was granted 39,894 shares of Dyadic International (a derivative holding)SEC Form 46 January 2026Restricted Stock Unit · traded 2 January 2026 · filed 6 January 2026
- exercised options over 21,552 shares of Dyadic InternationalSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- exercised options over 10,000 shares of uniQure (a derivative holding)SEC Form 46 November 2025Stock Option (Right to Buy) · traded 4 November 2025 · filed 6 November 2025
- exercised options over 11,000 shares of uniQure (a derivative holding)SEC Form 46 November 2025Stock Option (Right to Buy) · traded 4 November 2025 · filed 6 November 2025
- exercised options over 17,810 shares of uniQure (a derivative holding)SEC Form 46 November 2025Stock Option (Right to Buy) · traded 4 November 2025 · filed 6 November 2025
- exercised options over 10,000 shares of uniQureSEC Form 46 November 2025Ordinary Shares · traded 4 November 2025 · filed 6 November 2025
- ▼ sold on the open market 10,000 shares of uniQureSEC Form 46 November 2025Ordinary Shares · traded 4 November 2025 · filed 6 November 2025
- exercised options over 11,000 shares of uniQureSEC Form 46 November 2025Ordinary Shares · traded 4 November 2025 · filed 6 November 2025
- ▼ sold on the open market 11,000 shares of uniQureSEC Form 46 November 2025Ordinary Shares · traded 4 November 2025 · filed 6 November 2025
- exercised options over 17,810 shares of uniQureSEC Form 46 November 2025Ordinary Shares · traded 4 November 2025 · filed 6 November 2025
- ▼ sold on the open market 17,810 shares of uniQureSEC Form 46 November 2025Ordinary Shares · traded 4 November 2025 · filed 6 November 2025
- ▼ sold on the open market 2,112 shares of uniQureSEC Form 424 June 2025Ordinary Shares · traded 20 June 2025 · filed 24 June 2025
- was granted 15,630 shares of uniQure (a derivative holding)SEC Form 413 June 2025Stock Option (Right to Buy) · traded 11 June 2025 · filed 13 June 2025
- was granted 7,970 shares of uniQureSEC Form 413 June 2025Ordinary Shares · traded 11 June 2025 · filed 13 June 2025
- exercised options over 7,500 shares of Dyadic International (a derivative holding)SEC Form 47 March 2025Stock Option · traded 5 March 2025 · filed 7 March 2025
- exercised options over 22,500 shares of Dyadic International (a derivative holding)SEC Form 47 March 2025Stock Option · traded 5 March 2025 · filed 7 March 2025
- exercised options over 7,500 shares of Dyadic InternationalSEC Form 47 March 2025Common Stock · traded 5 March 2025 · filed 7 March 2025
- exercised options over 22,500 shares of Dyadic InternationalSEC Form 47 March 2025Common Stock · traded 5 March 2025 · filed 7 March 2025
- had shares withheld for tax on 27,517 shares of Dyadic InternationalSEC Form 47 March 2025Common Stock · traded 5 March 2025 · filed 7 March 2025
- exercised options over 23,585 shares of Dyadic International (a derivative holding)SEC Form 47 January 2025Restricted Stock Unit · traded 2 January 2025 · filed 7 January 2025
- was granted 67,500 shares of Dyadic International (a derivative holding)SEC Form 47 January 2025Stock Option · traded 2 January 2025 · filed 7 January 2025
- was granted 21,552 shares of Dyadic International (a derivative holding)SEC Form 47 January 2025Restricted Stock Unit · traded 2 January 2025 · filed 7 January 2025
- exercised options over 23,585 shares of Dyadic InternationalSEC Form 47 January 2025Common Stock · traded 2 January 2025 · filed 7 January 2025
- was granted 15,840 shares of uniQure (a derivative holding)SEC Form 421 June 2024Stock Option (Right to Buy) · traded 19 June 2024 · filed 21 June 2024
- was granted 8,080 shares of uniQureSEC Form 421 June 2024Ordinary Shares · traded 19 June 2024 · filed 21 June 2024
- ▼ sold on the open market 2,218 shares of uniQureSEC Form 417 June 2024Ordinary Shares · traded 13 June 2024 · filed 17 June 2024
- gave away 12,700 shares of uniQureSEC Form 46 February 2024Ordinary Shares · traded 23 June 2023 · filed 6 February 2024
- gave away 12,700 shares of uniQureSEC Form 46 February 2024Ordinary Shares · traded 23 June 2023 · filed 6 February 2024
- was granted 67,500 shares of Dyadic International (a derivative holding)SEC Form 44 January 2024Stock Option · traded 2 January 2024 · filed 4 January 2024
- was granted 23,585 shares of Dyadic International (a derivative holding)SEC Form 44 January 2024Restricted Stock Unit · traded 2 January 2024 · filed 4 January 2024
- exercised options over 27,174 shares of Dyadic International (a derivative holding)SEC Form 44 January 2024Restricted Stock Unit · traded 3 January 2024 · filed 4 January 2024
- exercised options over 27,174 shares of Dyadic InternationalSEC Form 44 January 2024Common Stock · traded 3 January 2024 · filed 4 January 2024
- was granted 17,060 shares of uniQure (a derivative holding)SEC Form 420 June 2023Stock Option (Right to Buy) · traded 13 June 2023 · filed 20 June 2023
- was granted 8,700 shares of uniQureSEC Form 420 June 2023Ordinary Shares · traded 13 June 2023 · filed 20 June 2023
- ▼ sold on the open market 2,280 shares of uniQureSEC Form 420 June 2023Ordinary Shares · traded 16 June 2023 · filed 20 June 2023
- ▼ sold on the open market 384 shares of uniQureSEC Form 41 March 2023Ordinary Shares · traded 27 February 2023 · filed 1 March 2023
- was granted 52,500 shares of Dyadic International (a derivative holding)SEC Form 45 January 2023Stock Option · traded 3 January 2023 · filed 5 January 2023
- was granted 27,174 shares of Dyadic International (a derivative holding)SEC Form 45 January 2023Restricted Stock Unit · traded 3 January 2023 · filed 5 January 2023
- gave away 33,150 shares of Dyadic InternationalSEC Form 45 January 2023Common Stock · traded 21 November 2022 · filed 5 January 2023
- gave away 33,150 shares of Dyadic InternationalSEC Form 45 January 2023Common Stock · traded 21 November 2022 · filed 5 January 2023
- was granted 17,810 shares of uniQure (a derivative holding)SEC Form 417 June 2022Stock Option (Right to Buy) · traded 15 June 2022 · filed 17 June 2022
- was granted 9,080 shares of uniQureSEC Form 417 June 2022Ordinary Shares · traded 15 June 2022 · filed 17 June 2022
- was granted 25,000 shares of Dyadic International (a derivative holding)SEC Form 414 June 2022Stock Option · traded 10 June 2022 · filed 14 June 2022
- ▼ sold on the open market 600 shares of uniQureSEC Form 42 March 2022Ordinary Shares · traded 28 February 2022 · filed 2 March 2022
- was granted 2,645 shares of uniQure (a derivative holding)SEC Form 428 February 2022Stock Option (Right to Buy) · traded 24 February 2022 · filed 28 February 2022
- was granted 1,534 shares of uniQureSEC Form 428 February 2022Ordinary Shares · traded 24 February 2022 · filed 28 February 2022
- was granted 52,500 shares of Dyadic International (a derivative holding)SEC Form 45 January 2022Stock Option · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 504 shares of uniQureSEC Form 44 March 2021Ordinary Shares · traded 2 March 2021 · filed 4 March 2021
- was granted 2,382 shares of uniQureSEC Form 41 March 2021Ordinary Shares · traded 25 February 2021 · filed 1 March 2021
- was granted 4,107 shares of uniQure (a derivative holding)SEC Form 41 March 2021Stock Option (Right to Buy) · traded 25 February 2021 · filed 1 March 2021
- was granted 52,500 shares of Dyadic International (a derivative holding)SEC Form 46 January 2021Stock Option · traded 4 January 2021 · filed 6 January 2021
- was granted 3,620 shares of uniQure (a derivative holding)SEC Form 42 March 2020Stock Option (Right to Buy) · traded 27 February 2020 · filed 2 March 2020
- was granted 2,063 shares of uniQureSEC Form 42 March 2020Ordinary Shares · traded 27 February 2020 · filed 2 March 2020
- ▼ sold on the open market 806 shares of uniQureSEC Form 430 January 2020Ordinary Shares · traded 28 January 2020 · filed 30 January 2020
- was granted 75,000 shares of Dyadic International (a derivative holding)SEC Form 43 January 2020Stock Option · traded 2 January 2020 · filed 3 January 2020
- was granted 25,000 shares of Dyadic International (a derivative holding)SEC Form 427 June 2019Stock Option · traded 25 June 2019 · filed 27 June 2019
- was granted 5,295 shares of uniQure (a derivative holding)SEC Form 431 January 2019Stock Option (Right to Buy) · traded 25 January 2019 · filed 31 January 2019
- was granted 3,230 shares of uniQureSEC Form 431 January 2019Ordinary Shares · traded 25 January 2019 · filed 31 January 2019
- ▼ sold on the open market 1,210 shares of uniQureSEC Form 431 January 2019Ordinary Shares · traded 28 January 2019 · filed 31 January 2019
- ▼ sold on the open market 2,878 shares of uniQureSEC Form 431 January 2018Ordinary Shares · traded 29 January 2018 · filed 31 January 2018
- was granted 4,792 shares of uniQureSEC Form 430 January 2018Ordinary Shares · traded 26 January 2018 · filed 30 January 2018
- was granted 6,390 shares of uniQure (a derivative holding)SEC Form 430 January 2018Stock Option (Right to Buy) · traded 26 January 2018 · filed 30 January 2018
- was granted 11,000 shares of uniQure (a derivative holding)SEC Form 431 January 2017Stock Option (Right to Buy) · traded 27 January 2017 · filed 31 January 2017
- was granted 11,000 shares of uniQure (a derivative holding)SEC Form 431 January 2017Restricted Stock Units · traded 27 January 2017 · filed 31 January 2017
- was granted 10,000 shares of Keryx BiopharmaceuticalsSEC Form 418 June 2015Common Stock · traded 17 June 2015 · filed 18 June 2015
- was granted 30,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 418 June 2015Stock Options (right to buy) · traded 17 June 2015 · filed 18 June 2015
- was granted 10,000 shares of Keryx BiopharmaceuticalsSEC Form 426 June 2014Common Stock · traded 24 June 2014 · filed 26 June 2014
- was granted 30,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 426 June 2014Stock Options (right to buy) · traded 24 June 2014 · filed 26 June 2014
- gave away 6,000 shares of Keryx BiopharmaceuticalsSEC Form 49 September 2013Common Stock · traded 6 September 2013 · filed 9 September 2013
- gave away 3,000 shares of Keryx BiopharmaceuticalsSEC Form 49 September 2013Common Stock · traded 6 September 2013 · filed 9 September 2013
- gave away 6,000 shares of Keryx BiopharmaceuticalsSEC Form 49 September 2013Common Stock · traded 6 September 2013 · filed 9 September 2013
- was granted 25,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 421 June 2013Stock Options (right to buy) · traded 19 June 2013 · filed 21 June 2013
- was granted 15,000 shares of Keryx BiopharmaceuticalsSEC Form 421 June 2013Common Stock · traded 19 June 2013 · filed 21 June 2013
- gave away 5,000 shares of Keryx BiopharmaceuticalsSEC Form 415 February 2013Common Stock · traded 27 June 2012 · filed 15 February 2013
- gave away 5,000 shares of Keryx BiopharmaceuticalsSEC Form 415 February 2013Common Stock · traded 27 June 2012 · filed 15 February 2013
- was granted 25,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 422 June 2012Stock Options (right to buy) · traded 20 June 2012 · filed 22 June 2012
- was granted 15,000 shares of Keryx BiopharmaceuticalsSEC Form 422 June 2012Common Stock · traded 20 June 2012 · filed 22 June 2012
- gave away 9,720 shares of Keryx BiopharmaceuticalsSEC Form 44 January 2012Common Stock · traded 3 January 2012 · filed 4 January 2012
- gave away 86,680 shares of Keryx BiopharmaceuticalsSEC Form 419 December 2011Common Stock · traded 15 December 2011 · filed 19 December 2011
- was granted 25,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 413 July 2011Stock Options (Right to Buy) · traded 22 June 2011 · filed 13 July 2011
- was granted 15,000 shares of Keryx BiopharmaceuticalsSEC Form 413 July 2011Common Stock · traded 22 June 2011 · filed 13 July 2011
- ▼ sold on the open market 20,000 shares of Keryx BiopharmaceuticalsSEC Form 48 December 2010Common Stock · traded 6 December 2010 · filed 8 December 2010
- ▼ sold on the open market 25,000 shares of Keryx BiopharmaceuticalsSEC Form 41 October 2010Common Stock · traded 29 September 2010 · filed 1 October 2010
- was granted 25,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 418 June 2010Stock Options (Right to buy) · traded 16 June 2010 · filed 18 June 2010
- was granted 15,000 shares of Keryx BiopharmaceuticalsSEC Form 418 June 2010Common Stock · traded 16 June 2010 · filed 18 June 2010
- was granted 30,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 422 September 2009Stock Options (Right to Buy) · traded 19 September 2009 · filed 22 September 2009
- was granted 10,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 418 June 2009Stock Options (Right to Buy) · traded 17 June 2009 · filed 18 June 2009
- was granted 75,000 shares of Keryx BiopharmaceuticalsSEC Form 418 June 2009Common Stock · traded 16 June 2009 · filed 18 June 2009
- ▲ bought on the open market 35,000 shares of Keryx BiopharmaceuticalsSEC Form 422 May 2009Common Stock · traded 22 May 2009 · filed 22 May 2009
- was granted 60,000 shares of Keryx BiopharmaceuticalsSEC Form 418 November 2008Common Stock · traded 14 November 2008 · filed 18 November 2008
- was granted 10,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 420 June 2008Stock Options (Right to Buy) · traded 18 June 2008 · filed 20 June 2008
- was granted 10,000 shares of Keryx Biopharmaceuticals (a derivative holding)SEC Form 422 June 2007Stock Options (Right to Buy) · traded 21 June 2007 · filed 22 June 2007
- ▲ bought on the open market 1,400 shares of Keryx BiopharmaceuticalsSEC Form 422 June 2007Common Stock · traded 19 June 2007 · filed 22 June 2007
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.